ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 182 filers reported holding ACORDA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 4.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $222,000 | -64.6% | 238,319 | -22.6% | 0.00% | -50.0% |
| Q4 2019 | $628,000 | -33.3% | 307,977 | -6.1% | 0.00% | -33.3% |
| Q3 2019 | $941,000 | -58.2% | 327,990 | +11.7% | 0.01% | -57.1% |
| Q2 2019 | $2,252,000 | -33.1% | 293,551 | +15.8% | 0.01% | -36.4% |
| Q1 2019 | $3,368,000 | -0.5% | 253,440 | +16.7% | 0.02% | -4.3% |
| Q4 2018 | $3,385,000 | +40.8% | 217,265 | +77.6% | 0.02% | +64.3% |
| Q3 2018 | $2,404,000 | +992.7% | 122,335 | +1499.2% | 0.01% | +1300.0% |
| Q2 2018 | $220,000 | -30.8% | 7,650 | -43.1% | 0.00% | -50.0% |
| Q1 2018 | $318,000 | -51.8% | 13,450 | -59.9% | 0.00% | -50.0% |
| Q2 2017 | $660,000 | -62.4% | 33,525 | -18.2% | 0.00% | -73.3% |
| Q4 2015 | $1,754,000 | +50.0% | 41,000 | -7.0% | 0.02% | +66.7% |
| Q3 2015 | $1,169,000 | +269.9% | 44,100 | +364.2% | 0.01% | +200.0% |
| Q1 2015 | $316,000 | -65.0% | 9,500 | -57.0% | 0.00% | -57.1% |
| Q4 2014 | $903,000 | – | 22,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |